Photon Beam Radiation Therapy
Sponsors
M.D. Anderson Cancer Center, Radiation Therapy Oncology Group, NRG Oncology, Emory University, Mayo Clinic
Conditions
GlioblastomaGliosarcomaGrade I MeningiomaGrade II MeningiomaGrade III MeningiomaIntracranial NeoplasmMuscle Invasive Bladder Urothelial CarcinomaNerve Sheath Neoplasm
Phase 1
Phase 2
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Active, not recruitingNCT02179086
Start: 2014-12-04End: 2026-12-31Target: 606Updated: 2026-01-14
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
RecruitingNCT07061964
Start: 2025-11-25End: 2027-07-31Target: 111Updated: 2026-04-03
Phase 3
Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer
Active, not recruitingNCT01893307
Start: 2013-08-26End: 2031-12-31Updated: 2026-02-24
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Active, not recruitingNCT01993810
Start: 2014-02-03End: 2028-10-31Updated: 2024-12-18
Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma
Active, not recruitingNCT05095376
Start: 2022-03-28End: 2026-08-08Updated: 2026-04-03
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
RecruitingNCT06625034
Start: 2025-02-02End: 2033-05-28Target: 108Updated: 2026-02-10